PharmAsia Market Study February 2000


Regular Price: USD 1,000.00

Special Price USD 700.00

30% OFF

* Required Fields

Regular Price: USD 1,000.00

Special Price USD 700.00


Be the first to review this product

Table of Contents

PharmAsia Market Study February 2000, PharmAsia February 2000 Market Study Respiratory Diseases in IndiaOverview and ScopeOverview and ScopeMarket Engineering Analysis of the Indian Respiratory Disease Market (1996-2006)Market DefinitionsMarket Engineering Research Measurement SystemChallenges Facing the Respiratory Disease Market in IndiaMarket Engineering Valuation and Revenue Forecasts (1996-2006)Market ForecastsMarket Engineering Research Analysis of the Asthma Therapeutic Market in India (1996 to 2006)Competitive StructureMarket Engineering Research Analysis of the Pneumonia Therapeutic Market in India (1996 to 2006)Competitive StructureMarket Engineering Research Analysis of the Tuberculosis Therapeutic Market in India (1996–2006)Competitive StructureProducts in the PipelineMarket Engineering Strategy for the Respiratory Disease Drug Market in IndiaMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsCreate Awareness of the Spread of Respiratory Diseases Along With the Dangers InvolvedMake the Packaging of TB Drugs and Antibiotics More User Friendly to the Final CustomerRegulatory/Government Update of the Pharmaceutical Market and its ImplicationsRegulatory/Government Update of the Pharmaceutical Market and its ImplicationsPDRC Recommends Changes in Existing Tax Structures to Encourage Investment in Pharmaceutical R&DDTAB to Impose Restrictions on Production of OxytocineIneffectiveness of DPCO Leads to Hike in Drug PricesBoard Set Up to Handle Consumer Grievances re Drugs and Pharmaceuticals Uniformity in License Fee Structure to be Brought AboutBriefs: A Quick Look atHealthcare Developments in IndiaGlaxo Extends Restructuring - Merges With Smithkline BeechamCadila Forays Into Antihepatitis MarketGalderma Introduces Products in the Indian MarketUnichem Propagates its Losartan Brand To Cardiologists Through InternetIpca Launches Website on MalariaNovo Nordisk Enters Into Agreement With CDRI.Baan Extends its ERP Solutions to the Healthcare Industry in IndiaLupin Sets Sail on Restructuring Exercise to Extend Product Portfolio.Indian Government Encourages Investment in the Phramaceutical IndustryRanbaxy Enters the U.S. and UK Markets With its Range of Antibiotic ProductsBARC Focuses on New Drug Delivery Systems Using Nuclear Techniques.

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.